Year: 2007
Type: article
Study design: Observational Study
Abstract: Background: Several studies have shown that Gleason Score (GS) is a strong predictor of adverse outcomes after prostatectomy for prostate cancer.Specifically, upgrading of tumors scored as GS=6 on initial biopsy, to a GS>6 on subsequent prostatectomy imposes a significant burden, given the aggressive behavior of cancers with GS>6.The current study was performed to identify demographic and biopsy variables that might predict such upgrading to GS>6 in a cohort of patients with GS=6.Design: A total of 647 prostate cancer patients diagnosed between 1999-2003 who had concurrent prostatectomy data and biopsy data available were identified in our database.From this, we selected a cohort of 184 patients with a biopsy GS=6.Clinical data including age, pre-biopsy PSA, and biopsy variables including percentage of positive biopsy sites (PPBS), highest percentage of cancer at any single site (hPCA), and presence of high-grade prostatic intra-epithelial neoplasia (HGPIN) or perineural invasion (PNI) were extracted.Multivariate logistic regression models (LRM) using a forward Wald method were constructed in SPSS 13 (Chicago, IL) to identify factors predictive of upgrading to GS>6.Results: From a total of 184 patients with GS=6, ninety-two cases (92) were upgraded to GS>6.Among the upgraded cases, 90 (97.8%) had upgrading to GS 7, and 1 each (1.1%) had upgrading to GS 8 and GS 9. LRM identified a model with two variables that had a statistically significant ability to predict upgrading, including pre-biopsy PSA (Odds Ratio 8.66; 2.03-37.49,95% CI) and hPCA (Odds Ratio 1.03, 1.01-1.05,95% CI).This two-parameter model yielded a predictive accuracy of 62.2%.None of the other variables (age, PPBS, presence of HGPIN or PNI) were included in the final model.Conclusions: The utilization of PSA and highest percentage of cancer at any single biopsy site will significantly help in decreasing the incidence of upgrading of GS on subsequent prostatectomy in a cohort of patient with GS=6 on the initial biopsy.This information may aid treating physicians in more precise risk stratification of patients with prostate cancer prior to therapeutic interventions.
Source: Laboratory Investigation
Language: English
Subfield: Urology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,480
OpenAlex ID: W4230355336
